Organovo Holdings Inc (NASDAQ: ONVO)’s stock price has increased by 187.26 compared to its previous closing price of 0.37. However, the company has seen a 178.22% increase in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-25 that SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) today announced that Eli Lilly and Company (NYSE:LLY) (“Lilly”) will acquire Organovo’s FXR program, including its lead asset, FXR314.
Is It Worth Investing in Organovo Holdings Inc (NASDAQ: ONVO) Right Now?
Additionally, the 36-month beta value for ONVO is 0.59. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ONVO is 17.12M and currently, short sellers hold a 0.42% ratio of that float. The average trading volume of ONVO on February 25, 2025 was 197.57K shares.
ONVO’s Market Performance
ONVO stock saw an increase of 178.22% in the past week, with a monthly gain of 209.94% and a quarterly increase of 202.86%. The volatility ratio for the week is 8.44%, and the volatility levels for the last 30 days are 7.62% for Organovo Holdings Inc (ONVO). The simple moving average for the last 20 days is 168.63% for ONVO stock, with a simple moving average of 88.94% for the last 200 days.
Analysts’ Opinion of ONVO
Many brokerage firms have already submitted their reports for ONVO stocks, with H.C. Wainwright repeating the rating for ONVO by listing it as a “Buy.” The predicted price for ONVO in the upcoming period, according to H.C. Wainwright is $2.50 based on the research report published on December 13, 2018 of the previous year 2018.
ONVO Trading at 172.04% from the 50-Day Moving Average
After a stumble in the market that brought ONVO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.08% of loss for the given period.
Volatility was left at 7.62%, however, over the last 30 days, the volatility rate increased by 8.44%, as shares surge +186.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +145.23% upper at present.
During the last 5 trading sessions, ONVO rose by +170.26%, which changed the moving average for the period of 200-days by +13.15% in comparison to the 20-day moving average, which settled at $0.3931. In addition, Organovo Holdings Inc saw 130.48% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ONVO
Current profitability levels for the company are sitting at:
- -102.93 for the present operating margin
- -0.19 for the gross margin
The net margin for Organovo Holdings Inc stands at -101.52. The total capital return value is set at -13.85. Equity return is now at value -378.40, with -194.66 for asset returns.
Based on Organovo Holdings Inc (ONVO), the company’s capital structure generated 0.74 points at debt to capital in total, while cash flow to debt ratio is standing at -9.53. The debt to equity ratio resting at 2.91. The interest coverage ratio of the stock is -2511.6.
Currently, EBITDA for the company is -14.81 million with net debt to EBITDA at 0.01. When we switch over and look at the enterprise to sales, we see a ratio of 189.44. The receivables turnover for the company is 4.69for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.72.
Conclusion
In conclusion, Organovo Holdings Inc (ONVO) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
